相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bevacizumab therapy in recurrent high grade glioma: Impact on local control and survival
A. Narayana et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications
D. P. Soares et al.
CLINICAL RADIOLOGY (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
Andrew D. Norden et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Brain tumor imaging in clinical trials
J. W. Henson et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
Walter Taal et al.
CANCER (2008)
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Novel anti-angiogenic therapies for malignant gliomas
Andrew D. Norden et al.
LANCET NEUROLOGY (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
Kathleen R. Lamborn et al.
NEURO-ONCOLOGY (2008)
Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
A. D. Norden et al.
NEUROLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Neuroimaging in Patients with Gliomas
Roland T. Ullrich et al.
SEMINARS IN NEUROLOGY (2008)
Response criteria for glioma
A. Gregory Sorensen et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Advanced MRI of adult brain tumors
Geoffrey S. Young
NEUROLOGIC CLINICS (2007)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Transient postictal MRI changes in patients with brain tumors may mimic disease progression
Michael A. Finn et al.
SURGICAL NEUROLOGY (2007)
The clinical value of proton magnetic resonance spectroscopy in adult brain tumours
N. A. Sibtain et al.
CLINICAL RADIOLOGY (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Clinical applications of PET in brain tumors
Wei Chen
JOURNAL OF NUCLEAR MEDICINE (2007)
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Clinical and radiographic features of peritumoral infarction following resection of glioblastoma
S. Ulmer et al.
NEUROLOGY (2006)
Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods
E Galanis et al.
NEURO-ONCOLOGY (2006)
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas
GD Shah et al.
NEURO-ONCOLOGY (2006)
Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury
JS Smith et al.
JOURNAL OF NEUROSURGERY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma
IF Parney et al.
JOURNAL OF NEUROSURGERY (2005)
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression
MCY de Wit et al.
NEUROLOGY (2004)
Advances in magnetic resonance imaging of brain tumours
J Rees
CURRENT OPINION IN NEUROLOGY (2003)
Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors
DA Ross et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors
KE Warren et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Comparison of diameter and perimeter methods for tumor volume calculation
AG Sorensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment
AJ Kumar et al.
RADIOLOGY (2000)
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption
JL Rubenstein et al.
NEOPLASIA (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
